Most Clicked StoriesMore >


Eli Lilly Alzheimer's drug fails clinical trial

DIA Global SmartBrief | Nov 29, 2016

Eli Lilly and Co. halted a large-scale trial of the drug solanezumab after it failed to achieve significant results in slowing cognitive decline in patients with mild Alzheimer's symptoms. Solanezumab is an antibody intended to reduce the buildup of amyloid plaques in the brain. The Wall Street Journal (tiered subscription model) (11/23) The New York Times (free-article access for SmartBrief readers) (11/23)


EMA releases analysis on challenges of CNS drug development

DIA Global SmartBrief | Dec 01, 2016

GSK to study injectable PrEP therapy

DIA Global SmartBrief | Dec 01, 2016

Senate Dems hope for changes to 21st Century Cures bill despite GOP deal

DIA Global SmartBrief | Nov 29, 2016

India permits 3 drugs banned in other countries

DIA Global SmartBrief | Nov 29, 2016

Japan plans annual review of drug prices

DIA Global SmartBrief | Nov 29, 2016

Scripps researchers move opioid vaccines to human trials

DIA Global SmartBrief | Dec 01, 2016

Trial of investigative HIV vaccine begins in South Africa

DIA Global SmartBrief | Nov 29, 2016

Johnson & Johnson seeks Actelion

DIA Global SmartBrief | Nov 29, 2016

Celgene's multiple myeloma drug gains NICE backing

DIA Global SmartBrief | Nov 29, 2016


Find DIA Global SmartBrief Issues by Date:



DIA News More >


DIA upcoming event highlights

DIA Global SmartBrief | Dec 01, 2016

Become a DIA member

DIA Global SmartBrief | Dec 01, 2016

Explore the November Journal

DIA Global SmartBrief | Nov 17, 2016

Customized Onsite Training

DIA Global SmartBrief | Nov 15, 2016

Reach your audience -- showcase your products and services at an upcoming DIA conference

DIA Global SmartBrief | Nov 10, 2016




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more